EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Pharmacokinetics of colistin in adult critically ill patients in South Africa

Veshni Pillay-Fuentes Lorente iD, Ahmed A Abulfathi, Julien S Marais iD, Jocelyn De Jong, Tracy Kellermann iD, Daniel Mashishi, Ryan Davids, Roland Van Rensburg iD, Usha Lalla, Adrie Bekker, Arifa Parker iD, Tamsin Lovelock und 2 weitere

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkag011 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Veshni Pillay-Fuentes Lorente und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa. Hauptthemen laut MEDLINE: Colistin, Critical Illness, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Harry Crossley Foundation, EDCTP, SNIP-Africa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To determine the PK of the pro-drug colistimethate sodium (CMS) and colistin in adult patients admitted to a South African critical care unit and to compare the PK with historical data. Materials and methods We conducted a prospective, observational, PK study in critically ill adult patients receiving intravenous colistin as part of standard of care. CMS was administered as a loading dose of either 9 million units (MU) or 12 MU followed by maintenance doses dependent on creatinine clearance (CrCl) at either 12- or 8-hourly. PK samples were collected at 1, 2, 4, 8, 12, 24 and 48 hours post-loading dose. CMS and colistin concentrations were analysed using liquid chromatography–tandem mass spectrometry. The PK of CMS and colistin were described using non-compartmental analysis in Phoenix WinNonlin.

Results

We enrolled 24 participants, 50% (12/24) were admitted with burns. Mean age was 42 years (SD ± 16.3) and mean CrCl was 140 mL/min (SD ± 58.7). The PK parameters following a loading dose of 9 MU were comparable to published data. Colistin AUC showed a negative correlation with white cell count (r = −0.63) and eGFR (r = −0.44). Probability of target attainment was acceptable at Acinetobacter baumannii minimum inhibitory concentrations <1 mg/L.

Conclusion

Our results are comparable to previously published literature. Notably, increasing eGFR and WCC decreased colistin AUC. Future work will adopt a population pharmacokinetic modelling approach to quantify and account for sources of variability, with the aim of informing individualized dosing strategies for this South African population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinCritical IllnessAnti-Bacterial AgentsHumansAdultSouth AfricaFemaleMaleMiddle AgedProspective StudiesTandem Mass SpectrometryChromatography, LiquidAgedYoung AdultAdministration, IntravenousPlasma

Substanzen

ColistinAnti-Bacterial Agentscolistinmethanesulfonic acid

Autor:innen und Institutionen

  • Division of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.
  • CDDS, Certara USA, Radnor, PA, USA.
  • Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
  • Department of Anaesthesiology and Critical Care, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Division of Pulmonology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.

ORCID-Profile: Veshni Pillay-Fuentes Lorente, Julien S Marais, Tracy Kellermann, Roland Van Rensburg, Arifa Parker, Eric H Decloedt

Förderung

  • Harry Crossley Foundation
  • EDCTP
  • SNIP-Africa

Zitieren

APA

Pillay-Fuentes Lorente, V., Abulfathi, A. A., Marais, J. S., De Jong, J., Kellermann, T., Mashishi, D., Davids, R., Van Rensburg, R., Lalla, U., Bekker, A., Parker, A., Lovelock, T., Reddy, K., & Decloedt, E. H. (2026). Pharmacokinetics of colistin in adult critically ill patients in South Africa. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag011

Vancouver

Pillay-Fuentes Lorente V, Abulfathi AA, Marais JS, De Jong J, Kellermann T, Mashishi D, et al. Pharmacokinetics of colistin in adult critically ill patients in South Africa. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag011

BibTeX
@article{PillayFuentesLorente2026,
  author = {Pillay-Fuentes Lorente, Veshni and Abulfathi, Ahmed A and Marais, Julien S and De Jong, Jocelyn and Kellermann, Tracy and Mashishi, Daniel and Davids, Ryan and Van Rensburg, Roland and Lalla, Usha and Bekker, Adrie and Parker, Arifa and Lovelock, Tamsin and Reddy, Kessendri and Decloedt, Eric H},
  title = {Pharmacokinetics of colistin in adult critically ill patients in South Africa},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkag011}
}
Kostenlos starten →